Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Effects of short term bioturbation by common voles on biogeochemical soil variables.

Wilske B, Eccard JA, Zistl-Schlingmann M, Hohmann M, Methler A, Herde A, Liesenjohann T, Dannenmann M, Butterbach-Bahl K, Breuer L.

PLoS One. 2015 May 8;10(5):e0126011. doi: 10.1371/journal.pone.0126011. eCollection 2015.

2.

Relevance of nonfunctional linear polyacrylic acid for the biodegradation of superabsorbent polymer in soils.

Bai M, Wilske B, Buegger F, Esperschütz J, Bach M, Frede HG, Breuer L.

Environ Sci Pollut Res Int. 2015 Apr;22(7):5444-52. doi: 10.1007/s11356-014-3772-0. Epub 2014 Nov 1.

PMID:
25367644
3.

Detection of Candidatus Neoehrlichia mikurensis, Borrelia burgdorferi sensu lato genospecies and Anaplasma phagocytophilum in a tick population from Austria.

Glatz M, Müllegger RR, Maurer F, Fingerle V, Achermann Y, Wilske B, Bloemberg GV.

Ticks Tick Borne Dis. 2014 Mar;5(2):139-44. doi: 10.1016/j.ttbdis.2013.10.006. Epub 2013 Dec 15.

PMID:
24345313
4.

Biodegradability of a polyacrylate superabsorbent in agricultural soil.

Wilske B, Bai M, Lindenstruth B, Bach M, Rezaie Z, Frede HG, Breuer L.

Environ Sci Pollut Res Int. 2014;21(16):9453-60. doi: 10.1007/s11356-013-2103-1. Epub 2013 Sep 14.

PMID:
24037296
5.

Borrelia bavariensis sp. nov. is widely distributed in Europe and Asia.

Margos G, Wilske B, Sing A, Hizo-Teufel C, Cao WC, Chu C, Scholz H, Straubinger RK, Fingerle V.

Int J Syst Evol Microbiol. 2013 Nov;63(Pt 11):4284-8. doi: 10.1099/ijs.0.052001-0. Epub 2013 Jul 9.

PMID:
23838444
6.

Biodegradability screening of soil amendments through coupling of wavelength-scanned cavity ring-down spectroscopy to multiple dynamic chambers.

Bai M, Köstler M, Kunstmann J, Wilske B, Gattinger A, Frede HG, Breuer L.

Rapid Commun Mass Spectrom. 2011 Dec 30;25(24):3683-9.

PMID:
22468324
7.

Detection of a large linear plasmid in Borrelia spielmanii isolate.

Lenčáková DH, Schulte-Spechtel U, Fingerle V, Pet'ko B, Wilske B.

Can J Microbiol. 2011 Apr;57(4):343-6. doi: 10.1139/w11-012.

PMID:
21491987
8.

A new Borrelia species defined by multilocus sequence analysis of housekeeping genes.

Margos G, Vollmer SA, Cornet M, Garnier M, Fingerle V, Wilske B, Bormane A, Vitorino L, Collares-Pereira M, Drancourt M, Kurtenbach K.

Appl Environ Microbiol. 2009 Aug;75(16):5410-6. doi: 10.1128/AEM.00116-09. Epub 2009 Jun 19.

9.

Poplar plantation has the potential to alter the water balance in semiarid Inner Mongolia.

Wilske B, Lu N, Wei L, Chen S, Zha T, Liu C, Xu W, Noormets A, Huang J, Wei Y, Chen J, Zhang Z, Ni J, Sun G, Guo K, McNulty S, John R, Han X, Lin G, Chen J.

J Environ Manage. 2009 Jun;90(8):2762-70. doi: 10.1016/j.jenvman.2009.03.004. Epub 2009 Apr 16.

PMID:
19375215
10.

Acylated cholesteryl galactosides are specific antigens of borrelia causing lyme disease and frequently induce antibodies in late stages of disease.

Stübs G, Fingerle V, Wilske B, Göbel UB, Zähringer U, Schumann RR, Schröder NW.

J Biol Chem. 2009 May 15;284(20):13326-34. doi: 10.1074/jbc.M809575200. Epub 2009 Mar 23.

11.

Identification and characterization of the factor H and FHL-1 binding complement regulator-acquiring surface protein 1 of the Lyme disease spirochete Borrelia spielmanii sp. nov.

Herzberger P, Siegel C, Skerka C, Fingerle V, Schulte-Spechtel U, Wilske B, Brade V, Zipfel PF, Wallich R, Kraiczy P.

Int J Med Microbiol. 2009 Feb;299(2):141-54. doi: 10.1016/j.ijmm.2008.06.005. Epub 2008 Aug 15.

PMID:
18706858
12.

Evaluation of recombinant line immunoblot for detection of Lyme disease in Slovakia: comparison with two other immunoassays.

Lencáková D, Fingerle V, Stefancíková A, Schulte-Spechtel U, Petko B, Schréter I, Wilske B.

Vector Borne Zoonotic Dis. 2008 Jun;8(3):381-90. doi: 10.1089/vbz.2007.0216.A.

PMID:
18279004
13.

Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.

Glatz M, Fingerle V, Wilske B, Ambros-Rudolph C, Kerl H, Müllegger RR.

Dermatology. 2008;216(2):93-103. doi: 10.1159/000111505. Epub 2008 Jan 23.

PMID:
18216470
14.

Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1.

Herzberger P, Siegel C, Skerka C, Fingerle V, Schulte-Spechtel U, van Dam A, Wilske B, Brade V, Zipfel PF, Wallich R, Kraiczy P.

Infect Immun. 2007 Oct;75(10):4817-25. Epub 2007 Jul 16.

15.

Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.

Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, Leonhard S, Hofmann H, Weber K, Pfister K, Strle F, Wilske B.

Int J Med Microbiol. 2008 Apr;298(3-4):279-90. Epub 2007 Jul 5.

PMID:
17616434
16.

Complementation of a Borrelia afzelii OspC mutant highlights the crucial role of OspC for dissemination of Borrelia afzelii in Ixodes ricinus.

Fingerle V, Goettner G, Gern L, Wilske B, Schulte-Spechtel U.

Int J Med Microbiol. 2007 Apr;297(2):97-107. Epub 2007 Jan 30.

PMID:
17267282
17.

Microbiological and serological diagnosis of Lyme borreliosis.

Wilske B, Fingerle V, Schulte-Spechtel U.

FEMS Immunol Med Microbiol. 2007 Feb;49(1):13-21. Review.

18.

Comparative genome analysis: selection pressure on the Borrelia vls cassettes is essential for infectivity.

Glöckner G, Schulte-Spechtel U, Schilhabel M, Felder M, Sühnel J, Wilske B, Platzer M.

BMC Genomics. 2006 Aug 16;7:211.

19.

[Stage-oriented treatment of Lyme borreliosis].

Fingerle V, Wilske B.

MMW Fortschr Med. 2006 Jun 22;148(25):39-41. Review. German.

PMID:
16859159
20.

[Ticks, tick bites and how best to remove the tick].

Fingerle V, Wilske B.

MMW Fortschr Med. 2006 Jun 22;148(25):30-2. Review. German.

PMID:
16859157
21.

Adhesion of Borrelia garinii to neuronal cells is mediated by the interaction of OspA with proteoglycans.

Rupprecht TA, Koedel U, Heimerl C, Fingerle V, Paul R, Wilske B, Pfister HW.

J Neuroimmunol. 2006 Jun;175(1-2):5-11. Epub 2006 Mar 6.

PMID:
16603253
23.

Prevalence of Borrelia burgdorferi s.l. OspA types in Ixodes ricinus ticks from selected localities in Slovakia and Poland.

Lencáková D, Hizo-Teufel C, Petko B, Schulte-Spechtel U, Stanko M, Wilske B, Fingerle V.

Int J Med Microbiol. 2006 May;296 Suppl 40:108-18. Epub 2006 Mar 10.

PMID:
16530478
24.

Role of birds in Thuringia, Germany, in the natural cycle of Borrelia burgdorferi sensu lato, the Lyme disease spirochaete.

Kipp S, Goedecke A, Dorn W, Wilske B, Fingerle V.

Int J Med Microbiol. 2006 May;296 Suppl 40:125-8. Epub 2006 Mar 10.

PMID:
16530003
25.

Mini erythema migrans--a sign of early Lyme borreliosis.

Weber K, Wilske B.

Dermatology. 2006;212(2):113-6.

PMID:
16484816
26.

Epidemiology and diagnosis of Lyme borreliosis.

Wilske B.

Ann Med. 2005;37(8):568-79. Review.

PMID:
16338759
27.

The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.

Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U.

Neurology. 2005 Aug 9;65(3):448-50.

PMID:
16087912
28.
29.

CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis.

Rupprecht TA, Koedel U, Muhlberger B, Wilske B, Fontana A, Pfister HW.

J Neurol. 2005 Jul;252(7):820-3. Epub 2005 Mar 6.

PMID:
15750703
30.

Guidelines for the diagnosis of tick-borne bacterial diseases in Europe.

Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoërsdorff A, Blanco JR, Caruso G, Cinco M, Fournier PE, Francavilla E, Jensenius M, Kazar J, Laferl H, Lakos A, Lotric Furlan S, Maurin M, Oteo JA, Parola P, Perez-Eid C, Peter O, Postic D, Raoult D, Tellez A, Tselentis Y, Wilske B; ESCMID Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella; European Network for Surveillance of Tick-Borne Diseases.

Clin Microbiol Infect. 2004 Dec;10(12):1108-32.

31.

Comparative analysis of the Borrelia garinii genome.

Glöckner G, Lehmann R, Romualdi A, Pradella S, Schulte-Spechtel U, Schilhabel M, Wilske B, Sühnel J, Platzer M.

Nucleic Acids Res. 2004 Nov 16;32(20):6038-46. Print 2004.

32.

[Tick-borne human pathogenic microorganisms found in Europe and those considered nonpathogenic. Part II: Bacteria, parasites and mixed infections].

Süss J, Fingerle V, Hunfeld KP, Schrader C, Wilske B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 May;47(5):470-86. Review. German.

PMID:
15205761
33.

Heterogeneity of the immunodominant surface protein VlsE among the three genospecies of Borrelia burgdorferi pathogenic for humans.

Göttner G, Schulte-Spechtel U, Wilske B.

Int J Med Microbiol. 2004 Apr;293 Suppl 37:172-3. No abstract available.

PMID:
15147003
34.

Borrelia burgdorferi s.l. OspA-types are widespread in Bavaria but show distinct local patterns.

Fingerle V, Michel H, Hettche G, Hizo-Teufel C, Wilske B.

Int J Med Microbiol. 2004 Apr;293 Suppl 37:165-6. No abstract available.

PMID:
15147001
35.

Significant improvement of the recombinant Borrelia IgG immunoblot for serodiagnosis of early neuroborreliosis.

Schulte-Spechtel U, Lehnert G, Liegl G, Fingerle V, Heimerl C, Johnson B, Wilske B.

Int J Med Microbiol. 2004 Apr;293 Suppl 37:158-60. No abstract available.

PMID:
15146999
36.

Diagnosis of lyme borreliosis in europe.

Wilske B.

Vector Borne Zoonotic Dis. 2003 Winter;3(4):215-27. Review.

PMID:
14733674
37.

An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types.

Michel H, Wilske B, Hettche G, Göttner G, Heimerl C, Reischl U, Schulte-Spechtel U, Fingerle V.

Med Microbiol Immunol. 2004 Nov;193(4):219-26. Epub 2003 Sep 12.

PMID:
13680214
38.

Prevalence of four species of Borrelia burgdorferi sensu lato and coinfection with Anaplasma phagocytophila in Ixodes ricinus ticks in central Germany.

Hildebrandt A, Schmidt KH, Wilske B, Dorn W, Straube E, Fingerle V.

Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):364-7. Epub 2003 Jun 3.

PMID:
12783276
39.

Clonal accumulation of activated CD8+ T cells in the central nervous system during the early phase of neuroborreliosis.

Jacobsen M, Zhou D, Cepok S, Nessler S, Happel M, Stei S, Wilske B, Sommer N, Hemmer B.

J Infect Dis. 2003 Mar 15;187(6):963-73. Epub 2003 Mar 6.

PMID:
12660943
40.
41.

Apodemus species mice are reservoir hosts of Borrelia garinii OspA serotype 4 in Switzerland.

Huegli D, Hu CM, Humair PF, Wilske B, Gern L.

J Clin Microbiol. 2002 Dec;40(12):4735-7.

42.

[Tick removed. Sending on to examination?].

Fingerle V, Wilske B.

MMW Fortschr Med. 2002 Sep 26;144(39):13. German. No abstract available.

PMID:
12422678
43.

Rickettsia monacensis sp. nov., a spotted fever group Rickettsia, from ticks (Ixodes ricinus) collected in a European city park.

Simser JA, Palmer AT, Fingerle V, Wilske B, Kurtti TJ, Munderloh UG.

Appl Environ Microbiol. 2002 Sep;68(9):4559-66.

44.

Risk factors in Lyme borreliosis: a German case-control study.

Fitzner J, Ammon A, Baumann I, Talaska T, Schönberg A, Stöbel K, Fingerle V, Wilske B, Petersen L.

Int J Med Microbiol. 2002 Jun;291 Suppl 33:220. No abstract available.

PMID:
12141752
45.

Seroprevalence of Borrelia infection in occupational tick-exposed people in Bavaria (Germany).

Reimer B, Erbas B, Lobbichler K, Truckenbrodt R, Gartner-Kothe U, Kapeller N, Hansen M, Fingerle V, Wilske B, von Sonnenburg F.

Int J Med Microbiol. 2002 Jun;291 Suppl 33:215. No abstract available.

PMID:
12141748
46.

Microbiological diagnosis in Lyme borreliosis.

Wilske B.

Int J Med Microbiol. 2002 Jun;291 Suppl 33:114-9. Review.

PMID:
12141735
47.

[Patient with questionable Lyme borreliosis. Which laboratory parameters validate your clinical suspicion?].

Wilske B, Fingerle V.

MMW Fortschr Med. 2002 May 30;144(22):29-32. German.

PMID:
12116568
48.
49.

Dynamics of dissemination and outer surface protein expression of different European Borrelia burgdorferi sensu lato strains in artificially infected Ixodes ricinus nymphs.

Fingerle V, Rauser S, Hammer B, Kahl O, Heimerl C, Schulte-Spechtel U, Gern L, Wilske B.

J Clin Microbiol. 2002 Apr;40(4):1456-63.

50.

Host cell-specific expression of a p44 epitope by the human granulocytic ehrlichiosis agent.

Jauron SD, Nelson CM, Fingerle V, Ravyn MD, Goodman JL, Johnson RC, Lobentanzer R, Wilske B, Munderloh UG.

J Infect Dis. 2001 Dec 1;184(11):1445-50. Epub 2001 Nov 13.

PMID:
11709787

Supplemental Content

Loading ...
Support Center